GATC Offers Sequencing with 454 Technology
Complete the form below to unlock access to ALL audio articles.
GATC has announced that it is now offering genome sequencing using the sequencing technology of 454 Life Sciences.
This makes GATC the largest commercial sequencing service provider in Europe with a total capacity of 15.6 giga bases per year.
Only by combining the traditional Sanger technology with the 454 technology, can genomes now be sequenced and analysed in half the usual project time, with a considerable reduction in the number of contigs and gaps.
The technology can also be employed for many other applications, e.g. for sequencing of whole transcriptomes in a single run or for in-depth mutation analysis of rare mutations at much lower costs.
"We believe that the 454 technology is an important step towards a new era of DNA sequencing," says Peter Pohl, CEO of GATC Biotech AG.
"We are very excited to be the first service provider in Europe who offers considerable time and cost advantages to the customers by integrating this innovative technology and combining it with the traditional Sanger method."
